Amgen (AMGN) Director Ishrak Omar Receives Restricted Stock Award

What Happened

• Ishrak Omar, a director of Amgen Inc., received an award of 85,169 restricted stock units (RSUs) on August 7, 2026. The grant is reported as an acquisition at $0.00 per share (a standard equity award, not a cash purchase).
• The filing shows the award includes 460 Dividend Equivalents (DEs) that are credited to the unvested RSUs and will be paid in shares upon vesting (with cash for any fractional shares).

Key Details

• Transaction date: 2026-08-07; Form 4 filed: 2026-08-10 (timely filing).
• Amount: 85,169 RSUs granted at $0.00; reported dollar value of this line item = $0 (grant).
• Shares owned after transaction: not disclosed in the provided Form 4 excerpt.
• Footnote: DEs granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and qualifying dividend reinvestment plan; DEs convert to shares one-for-one on the vesting schedule, plus cash for fractional shares.
• Transaction code: A = Award/Grant.

Context

• This was an equity grant (award), not an open-market purchase or sale, so it reflects compensation/board-equity practices rather than an immediate vote of market confidence.
• RSUs are typically subject to vesting conditions; the filing indicates DEs will be paid in shares when the underlying RSUs vest.